HHHarald Severin Hansen

Harald Severin Hansen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Harald Severin Hansen has a total of 273 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metabolomic profiling and accurate diagnosis of basal cell carcinoma by MALDI imaging and machine learning

    by Lauritz F. Brorsen, James S. McKenzie, Fernanda E. Pinto, Martin Glud, Harald S. Hansen, Merete Haedersdal, Zoltan Takats, Christian Janfelt, Catharina M. Lerche

    Basal cell carcinoma (BCC), the most common keratinocyte cancer, presents a substantial public health challenge due to its high prevalence. Traditional diagnostic methods, which rely on visual examination and histopathological analysis, do not include metabolomic data. This exploratory study aims to molecularly characterize BCC and diagnose tumour tissue by applying matrix‐assisted laser desorption ionization mass spectrometry imaging (MALDI‐MSI) and machine learning (ML). BCC tumour development was induced in a mouse model and tissue sections containing BCC (n = 12) were analysed. The study design involved three phases: (i) Model training, (ii) Model validation and (iii) Metabolomic analysis. The ML algorithm was trained on MS data extracted and labelled in accordance with histopathology. An overall classification accuracy of 99.0% was reached for the labelled data. Classification of unlabelled tissue areas aligned with the evaluation of a certified Mohs surgeon for 99.9% of the total tissue area, underscoring the model's high sensitivity and specificity in identifying BCC. Tentative metabolite identifications were assigned to 189 signals of importance for the recognition of BCC, each indicating a potential tumour marker of diagnostic value. These findings demonstrate the potential for MALDI‐MSI coupled with ML to characterize the metabolomic profile of BCC and to diagnose tumour tissue with high sensitivity and specificity. Further studies are needed to explore the potential of implementing integrated MS and automated analyses in the clinical setting.


  • Post-oral fat-induced satiation is mediated by endogenous CCK and GLP-1 in a fat self-administration mouse model

    by Vasiliki Vana, Michelle K. Lærke, Karen Kleberg, Piotr A. Mroz, Birgit L. Lindberg, Jeppe H. Ekberg, Jens F. Rehfeld, Thue W. Schwartz, Harald S. Hansen


  • Open Access

    Essentiality of n-6 fatty acids

    by Harald S. Hansen


  • Non‐endocannabinoid N‐acylethanolamines and 2‐monoacylglycerols in the intestine

    by Harald S Hansen, Vasiliki Vana

    This review focuses on recent findings of the physiological and pharmacological role of non‐endocannabinoid N‐acylethanolamines (NAEs) and 2‐monoacylglycerols (2‐MAGs) in the intestine and their involvement in the gut‐brain signalling. Dietary fat suppresses food intake, and much research concerns the known gut peptides, for example, glucagon‐like peptide‐1 (GLP‐1) and cholecystokinin (CCK). NAEs and 2‐MAGs represent another class of local gut signals most probably involved in the regulation of food intake. We discuss the putative biosynthetic pathways and targets of NAEs in the intestine as well as their anorectic role and changes in intestinal levels depending on the dietary status. NAEs can activate the transcription factor PPARα, but studies to evaluate the role of endogenous NAEs are generally lacking. Finally, we review the role of diet‐derived 2‐MAGs in the secretion of anorectic gut peptides via activation of GPR119. Both PPARα and GPR119 have potential as pharmacological targets for the treatment of obesity and the former for treatment of intestinal inflammation.Linked Articles: This article is part of a themed section on 8th European Workshop on Cannabinoid Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.10/issuetoc


  • Open Access

    Mass spectrometry imaging of biomarker lipids for phagocytosis and signalling during focal cerebral ischaemia

    by Mette M. B. Nielsen, Kate L. Lambertsen, Bettina H. Clausen, Morten Meyer, Dhaka R. Bhandari, Søren T. Larsen, Steen S. Poulsen, Bernhard Spengler, Christian Janfelt, Harald S. Hansen

    Focal cerebral ischaemia has an initial phase of inflammation and tissue injury followed by a later phase of resolution and repair. Mass spectrometry imaging (desorption electrospray ionization and matrix assisted laser desorption ionization) was applied on brain sections from mice 2 h, 24 h, 5d, 7d, and 20d after permanent focal cerebral ischaemia. Within 24 h, N-acyl-phosphatidylethanolamines, lysophosphatidylcholine, and ceramide accumulated, while sphingomyelin disappeared. At the later resolution stages, bis(monoacylglycero)phosphate (BMP(22:6/22:6)), 2-arachidonoyl-glycerol, ceramide-phosphate, sphingosine-1-phosphate, lysophosphatidylserine, and cholesteryl ester appeared. At day 5 to 7, dihydroxy derivates of docosahexaenoic and docosapentaenoic acid, some of which may be pro-resolving mediators, e.g. resolvins, were found in the injured area, and BMP(22:6/22:6) co-localized with the macrophage biomarker CD11b, and probably with cholesteryl ester. Mass spectrometry imaging can visualize spatiotemporal changes in the lipidome during the progression and resolution of focal cerebral inflammation and suggests that BMP(22:6/22:6) and N-acyl-phosphatidylethanolamines can be used as biomarkers for phagocytizing macrophages/microglia cells and dead neurones, respectively.


  • Open Access

    Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119

    by Helle A. Hassing, Suzan Fares, Olav Larsen, Hamideh Pad, Maria Hauge, Robert M. Jones, Thue W. Schwartz, Harald S. Hansen, Mette M. Rosenkilde


  • Oral 2‐oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor

    by H.A. Hassing, M.S. Engelstoft, R.M. Sichlau, A.N. Madsen, J.F. Rehfeld, J. Pedersen, R.M. Jones, J.J. Holst, T.W. Schwartz, M.M. Rosenkilde, et al.

    The intestinal G protein‐coupled receptor GPR119 is a novel metabolic target involving glucagon‐like peptide‐1 (GLP‐1)‐derived insulin‐regulated glucose homeostasis. Endogenous and diet‐derived lipids, including N‐acylethanolamines and 2‐monoacylglycerols (2‐MAG) activate GPR119. The purpose of this work is to evaluate whether 2‐oleoyl glycerol (2‐OG) improves glucose tolerance through GPR119, using wild type (WT) and GPR 119 knock out (KO) mice. We here show that GPR119 is essential for 2‐OG‐mediated release of GLP‐1 and CCK from GLUTag cells, since a GPR119 specific antagonist completely abolished the hormone release. Similarly, in isolated primary colonic crypt cultures from WT mice, GPR119 was required for 2‐OG‐stimulated GLP‐1 release while there was no response in crypts from KO mice. In vivo, gavage with 2‐oleyl glyceryl ether ((2‐OG ether), a stable 2‐OG analog with a potency of 5.3 µM for GPR119 with respect to cAMP formation as compared to 2.3 µM for 2‐OG), significantly (P < 0.05) improved glucose clearance in WT littermates, but not in GPR119 KO mice. Finally, deletion of GPR119 in mice resulted in lower glucagon levels, whereas the levels of insulin and GIP were unchanged. In the present study we show that 2‐OG stimulates GLP‐1 secretion through GPR119 activation in vitro, and that fat‐derived 2‐MAGs are potent candidates for mediating fat‐induced GLP‐1 release through GPR119 in vivo. © 2016 BioFactors, 42(6):665–673, 2016


  • The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans

    by Mette J Mandøe, Katrine B Hansen, Bolette Hartmann, Jens F Rehfeld, Jens J Holst, Harald S Hansen

    Background: Dietary triglycerides can, after digestion, stimulate the intestinal release of incretin hormones through activation of G protein–coupled


  • Evaluation of the immediate vascular stability of lipoprotein lipase‐generated 2‐monoacylglycerol in mice

    by Karen Kleberg, Louise Lundeman Nielsen, Nicolai Stuhr‐Hansen, John Nielsen, Harald Severin Hansen

    2‐Monoacylglycerols are gaining increasing interest as signaling lipids, beyond endocannabinoids, for example, as ligands for the receptor GPR119 and as mediators of insulin secretion. In the vascular system, they are formed by the action of lipoprotein lipase (LPL); however, their further disposition is unclear. Assuming similar affinity for uptake and incorporation into tissues of 2‐oleoylglycerol and 2‐oleylglyceryl ether, we have synthesized a3H‐labeled 2‐ether analog of triolein (labeled in alkyl group) and compared its disposition with14C‐labeled triolein (labeled in glycerol) 20 min after intravenous coadministration in a ratio of 1:1 to mice. We found that peripheral tissues and the liver in particular are able to take up 2‐monoacylglycerols as seen from3H uptake. In muscle and adipose tissue, 2‐monoacylglycerols are probably further hydrolyzed as seen by an increased3H/14C ratio, whereas in the liver and the heart, data suggest that they are also subjected to re‐esterification to triacylglycerol, as seen by an unchanged3H/14C ratio in the lipid fraction of the tissues. Our findings suggest that LPL‐generated 2‐monoacylglycerol is likely to be stable in the vascular system and thus have a potential to circulate or at least exert effects in tissues where it may be locally produced. © 2014 BioFactors, 40(6):596–602, 2014